Toragen Key Start-Up Accomplishments
- $1.4 million of Angel and Seed Capital raised
- UCSD PCT Patent filed
- Technology Licensed from UCSD
- Developed Regulatory Strategy
- Met with FDA in pre-IND Meeting
- FDA agreed to a ‘Fast Track’ 505(b)(2) Strategy
- GMP Active Product Ingredient Manufactured
- Pre-formulation completed
- Filed a Second Patent on Proprietary Technology
- Ready to begin Phase I Clinical Trial with Funding
Toragen, Inc. 